234 related articles for article (PubMed ID: 29922930)
1. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Takumi K; Maemura K; Higashi M; Kamimura K; Nakajo M; Yoshiura T
Eur Radiol; 2019 Jan; 29(1):353-361. PubMed ID: 29922930
[TBL] [Abstract][Full Text] [Related]
2. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms.
Iwaya H; Fukukura Y; Hashimoto S; Tanoue S; Kawahira M; Hinokuchi M; Fujita T; Komaki Y; Arima S; Sasaki F; Kanmura S; Higashi M; Tamada K; Ido A
Pancreatology; 2021 Jun; 21(4):779-786. PubMed ID: 33714670
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
[TBL] [Abstract][Full Text] [Related]
5. Increased tumour ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer.
Nishiofuku H; Tanaka T; Marugami N; Sho M; Akahori T; Nakajima Y; Kichikawa K
Eur Radiol; 2016 Jun; 26(6):1835-42. PubMed ID: 26385808
[TBL] [Abstract][Full Text] [Related]
6. Estimation of pancreatic fibrosis and prediction of postoperative pancreatic fistula using extracellular volume fraction in multiphasic contrast-enhanced CT.
Sofue K; Ueshima E; Masuda A; Shirakawa S; Zen Y; Ueno Y; Tsujita Y; Yamaguchi T; Yabe S; Tanaka T; Inomata N; Toyama H; Fukumoto T; Kodama Y; Murakami T
Eur Radiol; 2022 Mar; 32(3):1770-1780. PubMed ID: 34636963
[TBL] [Abstract][Full Text] [Related]
7. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
[TBL] [Abstract][Full Text] [Related]
9. Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Fujita N; Ushijima Y; Itoyama M; Okamoto D; Ishimatsu K; Wada N; Takao S; Murayama R; Fujimori N; Nakata K; Nakamura M; Yamamoto T; Oda Y; Ishigami K
Eur J Radiol; 2023 May; 162():110756. PubMed ID: 36907069
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Fractional Extracellular Space at CT for Predicting Chemotherapy Response and Survival in Pancreatic Ductal Adenocarcinoma.
Wang ZJ; Zhang TT; An C; Ko AH; Tempero M; Collisson E; Yeh BM
AJR Am J Roentgenol; 2020 Sep; 215(3):610-616. PubMed ID: 32755156
[No Abstract] [Full Text] [Related]
11. Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer.
Wang Z; Ye Y; Hu Y; Han S; Sun L; Xu D; Ding K
Eur Radiol; 2019 Mar; 29(3):1114-1123. PubMed ID: 30255251
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.
Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Ohtsuka T; Yoshizumi T; Aishima S; Oda Y; Honda H
Eur Radiol; 2017 Jun; 27(6):2563-2569. PubMed ID: 27752833
[TBL] [Abstract][Full Text] [Related]
13. Multidetector CT of pancreatic ductal adenocarcinoma: Effect of tube voltage and iodine load on tumour conspicuity and image quality.
Loizou L; Albiin N; Leidner B; Axelsson E; Fischer MA; Grigoriadis A; Del Chiaro M; Segersvärd R; Verbeke C; Sundin A; Kartalis N
Eur Radiol; 2016 Nov; 26(11):4021-4029. PubMed ID: 26965503
[TBL] [Abstract][Full Text] [Related]
14. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.
Bae JS; Kim JH; Joo I; Chang W; Han JK
Eur Radiol; 2019 Jul; 29(7):3714-3724. PubMed ID: 30899975
[TBL] [Abstract][Full Text] [Related]
15. Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast.
Patel BN; Thomas JV; Lockhart ME; Berland LL; Morgan DE
Clin Radiol; 2013 Feb; 68(2):148-54. PubMed ID: 22889459
[TBL] [Abstract][Full Text] [Related]
16. Extracellular volume fraction derived from dual-energy CT: a potential predictor for acute pancreatitis after pancreatoduodenectomy.
Bai XH; Yin J; Yu SY; Shu YP; Lu ZP; Jiang KR; Xu Q
Eur Radiol; 2024 May; ():. PubMed ID: 38760508
[TBL] [Abstract][Full Text] [Related]
17. Extracellular volume fraction determined by equilibrium contrast-enhanced computed tomography: correlation with histopathological findings in gastric cancer.
Nishimuta Y; Tsurumaru D; Kai S; Maehara J; Asayama Y; Oki E; Ishigami K
Jpn J Radiol; 2023 Jul; 41(7):752-759. PubMed ID: 36735208
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer.
Fukui H; Onishi H; Nakamoto A; Tsuboyama T; Ota T; Yano K; Enchi Y; Yamada D; Takeda Y; Kobayashi S; Fukuda Y; Eguchi H; Matsui T; Tatsumi M; Tomiyama N
Eur J Radiol; 2022 Nov; 156():110522. PubMed ID: 36113381
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
